Markets:

Overview

News

Currencies

International

Treasuries

Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

14.75 -2.71 (-15.52%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Adaptive Biotechnologies Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Adaptive Biotechnologies to Report First Quarter Financial Results on May 3, 2023

April 06, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Luminar Technologies, EHang Holdings And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 22, 2023

U.S. stock futures traded slightly lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Adaptive Biotechnologies to Participate in the 43rd Annual Cowen Healthcare Conference

February 27, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Trade Desk, Roblox, Herbalife And Other Big Stocks Moving Higher On Wednesday ↗

February 15, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

What To Know About Piper Sandler's Upgrade of Adaptive Biotechnologies ↗

December 21, 2022

Via Benzinga

Looking Into Adaptive Biotechnologies's Return On Capital Employed ↗

November 25, 2022

Via Benzinga

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results

February 14, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 13, 2023

Via Benzinga

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023

January 23, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference

December 27, 2022

From Adaptive Biotechnologies

Via GlobeNewswire

Expert Ratings for Adaptive Biotechnologies ↗

November 07, 2022

Adaptive Biotechnologies (NASDAQ:ADPT) has observed the following analyst ratings within the last quarter:

Via Benzinga

Adaptive Biotechnologies Earnings Perspective: Return On Capital Employed ↗

August 11, 2022

Via Benzinga

Earnings Scheduled For February 14, 2023 ↗

February 14, 2023

Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session ↗

December 21, 2022

Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical...

Via Benzinga

Nike, FedEx And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

December 21, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022 ↗

December 21, 2022

Via Benzinga

Adaptive Biotechnologies Highlights New Data Showcasing the Clinical Utility of clonoSEQ® MRD Testing in Patients with Blood Cancers at the 64th ASH Annual Meeting

December 10, 2022

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Clinical Utility and Benefit of clonoSEQ® MRD Testing in Blood Cancer Patients at 2022 ASH Annual Meeting

December 05, 2022

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies Announces Launch of clonoSEQ® to Assess Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using Circulating Tumor DNA (ctDNA)

December 01, 2022

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies to Participate in the Piper Sandler Healthcare Conference

November 21, 2022

From Adaptive Biotechnologies

Via GlobeNewswire

New Survey Reveals the Majority of Myeloma Patients That Undergo Minimal Residual Disease (MRD) Testing Find a Clear Clinical or Emotional Benefit from Results

November 21, 2022

From Adaptive Biotechnologies

Via GlobeNewswire

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗

November 11, 2022

Gainers

Via Benzinga

5 Top Stocks Cathie Wood Is Buying This Week ↗

November 04, 2022

Cathie Wood just lauded Elon Musk's acquisition of Twitter, believing the platform will become a "super-app." Here are her top five buys.

Via InvestorPlace

Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results

November 03, 2022

From Adaptive Biotechnologies

Via GlobeNewswire

General Electric To Surge Around 27%? Plus This Analyst Predicts $44 For General Motors ↗

October 26, 2022

RBC Capital raised the price target on General Electric Company (NYSE: GE) from $81 to $93. General Electric shares fell 0.5% to close at $73.00 on Tuesday.

Via Benzinga

Adaptive Announces Partnership with Epic to Increase Access to Minimal Residual Disease (MRD) Monitoring in Blood Cancers

October 11, 2022

Integration with the most widely used comprehensive electronic health record will expand clinician and patient access to clonoSEQ

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies to Report Third Quarter of 2022 Financial Results on November 3, 2022

October 05, 2022

From Adaptive Biotechnologies

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.